Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,882 | 61 | 57.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,750 | 1 | 32.6% |
| Travel and Lodging | $806.34 | 2 | 9.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $3,338 | 6 | $0 (2023) |
| Regeneron Pharmaceuticals, Inc. | $806.34 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $738.64 | 6 | $0 (2019) |
| Alcon Laboratories Inc | $649.02 | 7 | $0 (2018) |
| Genentech USA, Inc. | $620.89 | 9 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $560.29 | 7 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $241.77 | 2 | $0 (2022) |
| Shire North American Group Inc | $172.65 | 2 | $0 (2018) |
| Dutch Ophthalmic, USA | $166.83 | 1 | $0 (2019) |
| Sight Sciences, Inc. | $156.04 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $589.67 | 11 | Genentech USA, Inc. ($186.68) |
| 2023 | $3,045 | 6 | Alcon Vision LLC ($2,863) |
| 2022 | $862.02 | 10 | Genentech USA, Inc. ($328.61) |
| 2021 | $388.35 | 5 | Spark Therapeutics, Inc. ($125.00) |
| 2020 | $102.02 | 1 | Alcon Vision LLC ($102.02) |
| 2019 | $1,980 | 12 | Regeneron Pharmaceuticals, Inc. ($806.34) |
| 2018 | $1,471 | 19 | Alcon Laboratories Inc ($649.02) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/09/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $119.93 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/21/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: Ophthalmology | ||||||
| 10/11/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $32.73 | General |
| Category: Ophthalmology | ||||||
| 08/15/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Ophthalmology | ||||||
| 06/14/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: Ophthalmology | ||||||
| 06/10/2024 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/30/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/15/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/01/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $32.36 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/21/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $156.04 | General |
| Category: Ophthalmology | ||||||
| 01/24/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $4.43 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/24/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $120.67 | General |
| Category: DRY EYE | ||||||
| 09/20/2023 | Alcon Vision LLC | Rhopressa (Drug), Rocklatan, Simbrinza | Food and Beverage | In-kind items and services | $113.46 | General |
| Category: Ophthalmology | ||||||
| 09/08/2023 | Alcon Vision LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: Ophthalmology | ||||||
| 09/01/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $18.85 | General |
| 05/08/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $17.49 | General |
| 04/19/2023 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $24.77 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/28/2022 | Coherus Biosciences Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Ophthalmology | ||||||
| 11/02/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/18/2022 | GlaxoSmithKline, LLC. | BLENREP (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 10/05/2022 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Ophthalmology | ||||||
| 09/16/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $9.44 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/19/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $149.04 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/13/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $119.76 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/22/2022 | Genentech USA, Inc. | SUSVIMO (Drug) | Food and Beverage | In-kind items and services | $134.32 | General |
| Category: Immunology and Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 874 | 1,391 | $371,951 | $88,731 |
| 2022 | 13 | 1,101 | 1,965 | $759,400 | $155,489 |
| 2021 | 10 | 837 | 1,553 | $581,000 | $120,199 |
| 2020 | 11 | 593 | 775 | $304,995 | $60,515 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 67028 | Injection of drug into eye | Office | 2023 | 54 | 176 | $119,147 | $15,571 | 13.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 111 | 194 | $29,590 | $12,457 | 42.1% |
| 92134 | Imaging of retina | Office | 2023 | 183 | 309 | $55,041 | $10,225 | 18.6% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 13 | 14 | $59,344 | $9,477 | 16.0% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 110 | 207 | $24,820 | $8,404 | 33.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 62 | 62 | $20,873 | $8,035 | 38.5% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 58 | 60 | $17,122 | $7,368 | 43.0% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 39 | 47 | $13,464 | $5,401 | 40.1% |
| 92082 | Exam of visual field with intermediate testing | Office | 2023 | 60 | 84 | $8,400 | $3,312 | 39.4% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 11 | 48 | $7,064 | $2,775 | 39.3% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 91 | 105 | $5,691 | $2,284 | 40.1% |
| 92250 | Photography of the retina | Office | 2023 | 61 | 64 | $6,671 | $1,960 | 29.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $4,725 | $1,464 | 31.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 161 | 377 | $56,550 | $29,325 | 51.9% |
| 67028 | Injection of drug into eye | Office | 2022 | 62 | 262 | $262,000 | $25,109 | 9.6% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 122 | 176 | $44,000 | $19,893 | 45.2% |
| 67041 | Removal of membrane of retina | Facility | 2022 | 17 | 17 | $93,500 | $17,105 | 18.3% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2022 | 17 | 18 | $99,000 | $13,404 | 13.5% |
| 92134 | Imaging of retina | Office | 2022 | 183 | 358 | $89,500 | $12,151 | 13.6% |
| 92082 | Exam of visual field with intermediate testing | Office | 2022 | 139 | 258 | $25,800 | $10,597 | 41.1% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2022 | 109 | 142 | $28,400 | $5,722 | 20.1% |
| 92250 | Photography of the retina | Office | 2022 | 122 | 178 | $22,250 | $5,487 | 24.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 61 | 61 | $13,725 | $5,393 | 39.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 50 | 60 | $12,000 | $4,920 | 41.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 43 | 43 | $9,675 | $4,589 | 47.4% |
About Dr. Wei Gui, M.D
Dr. Wei Gui, M.D is a Ophthalmology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2014. The National Provider Identifier (NPI) number assigned to this provider is 1679980882.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wei Gui, M.D has received a total of $8,438 in payments from pharmaceutical and medical device companies, with $589.67 received in 2024. These payments were reported across 64 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,882).
As a Medicare-enrolled provider, Gui has provided services to 3,405 Medicare beneficiaries, totaling 5,684 services with total Medicare billing of $424,934. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Los Angeles, CA
- Active Since 07/20/2014
- Last Updated 09/21/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679980882
Products in Payments
- AcrySof (Device) $577.93
- Constellation (Device) $349.07
- EYLEA (Biological) $315.36
- Cequa (Drug) $241.77
- Vabysmo (Drug) $204.46
- VABYSMO (Drug) $194.29
- XIIDRA (Drug) $172.65
- EVA Ophthalmic Surgical System (Device) $166.83
- OMNI SURGICAL SYSTEM (Device) $156.04
- ACTIVEFOCUS (Device) $155.86
- SUSVIMO (Drug) $134.32
- Tecnis 1-piece IOL (Device) $125.67
- OZURDEX (Drug) $125.26
- BEOVU (Drug) $125.00
- BLENREP (Biological) $125.00
- EYLEA AFLIBERCEPT INJECTION (Biological) $125.00
- OMIDRIA (Drug) $124.99
- TYRVAYA (Drug) $120.67
- EYLEA HD (Biological) $119.93
- Rhopressa (Drug) $113.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Los Angeles
Dr. Andrew Moshfeghi, Md, MD
Ophthalmology — Payments: $898,549
Dr. Barry Seibel, M.d, M.D
Ophthalmology — Payments: $893,403
Neda Shamie, M.d, M.D
Ophthalmology — Payments: $693,812
David Boyer, Md, MD
Ophthalmology — Payments: $514,544
David Hamilton, Od, OD
Ophthalmology — Payments: $477,856
Dr. Nicole Fram, Md, MD
Ophthalmology — Payments: $382,620